DK1427436T3 - Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion - Google Patents
Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektionInfo
- Publication number
- DK1427436T3 DK1427436T3 DK02796345T DK02796345T DK1427436T3 DK 1427436 T3 DK1427436 T3 DK 1427436T3 DK 02796345 T DK02796345 T DK 02796345T DK 02796345 T DK02796345 T DK 02796345T DK 1427436 T3 DK1427436 T3 DK 1427436T3
- Authority
- DK
- Denmark
- Prior art keywords
- mixture
- viral infection
- microbial
- prophylaxis
- treatment
- Prior art date
Links
- 235000013336 milk Nutrition 0.000 title abstract 3
- 239000008267 milk Substances 0.000 title abstract 3
- 210000004080 milk Anatomy 0.000 title abstract 3
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- 102000004506 Blood Proteins Human genes 0.000 title 1
- 108010017384 Blood Proteins Proteins 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- 102000006410 Apoproteins Human genes 0.000 abstract 2
- 108010083590 Apoproteins Proteins 0.000 abstract 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000007922 nasal spray Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000003182 parenteral nutrition solution Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IES20010780 | 2001-08-23 | ||
| PCT/IE2002/000121 WO2003018049A2 (en) | 2001-08-23 | 2002-08-20 | Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1427436T3 true DK1427436T3 (da) | 2008-10-13 |
Family
ID=11042830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02796345T DK1427436T3 (da) | 2001-08-23 | 2002-08-20 | Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7687074B2 (da) |
| EP (1) | EP1427436B1 (da) |
| JP (1) | JP4532900B2 (da) |
| KR (1) | KR100907959B1 (da) |
| CN (1) | CN1578670B (da) |
| AT (1) | ATE399562T1 (da) |
| AU (1) | AU2002356112B2 (da) |
| CA (1) | CA2458146C (da) |
| DE (1) | DE60227389D1 (da) |
| DK (1) | DK1427436T3 (da) |
| ES (1) | ES2309228T3 (da) |
| NZ (1) | NZ531639A (da) |
| PT (1) | PT1427436E (da) |
| RU (1) | RU2305547C2 (da) |
| WO (1) | WO2003018049A2 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2863168A1 (fr) * | 2003-12-04 | 2005-06-10 | Centre Nat Rech Scient | Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone. |
| CN101043884A (zh) * | 2004-07-01 | 2007-09-26 | 谢彭斯眼科研究公司 | 用于治疗眼部疾病和病症的组合物和方法 |
| WO2007035870A2 (en) * | 2005-09-20 | 2007-03-29 | Prolacta Bioscience, Inc. | A method for testing milk |
| AU2006318655B2 (en) * | 2005-11-18 | 2013-03-28 | Glanbia Nutritionals (Ireland) Ltd. | Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| JP5017531B2 (ja) * | 2006-09-11 | 2012-09-05 | 株式会社アップウェル | 口内清浄剤 |
| US20100317734A1 (en) * | 2007-12-04 | 2010-12-16 | Michael Anthony Folan | Free fatty acid blends and use thereof |
| JP2009190994A (ja) * | 2008-02-13 | 2009-08-27 | Kitasato Institute | 抗インフルエンザウイルス剤、及びその有効成分の製造方法 |
| KR101274543B1 (ko) * | 2008-06-11 | 2013-06-17 | 리콤 코포레이션 | 인간 아드레날린 β３ 수용체 리간드, 이를 포함하는 식품 및 의약품 |
| US20090311236A1 (en) * | 2008-06-11 | 2009-12-17 | Immune @Work, Inc. | Therapeutic Peptide Compositions And Methods Of Making And Using Same |
| US8808345B2 (en) * | 2008-12-31 | 2014-08-19 | Medtronic Ardian Luxembourg S.A.R.L. | Handle assemblies for intravascular treatment devices and associated systems and methods |
| WO2010082587A1 (ja) * | 2009-01-13 | 2010-07-22 | 株式会社大気倶楽部 | 空中懸濁物吸着剤 |
| KR101119538B1 (ko) * | 2009-06-10 | 2012-02-22 | 장선호 | 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방 및 치료용 조성물 |
| CA2781550C (en) | 2009-11-17 | 2018-01-23 | Michael Anthony Folan | Antimicrobial compositions containing free fatty acids |
| AR082943A1 (es) * | 2010-08-06 | 2013-01-23 | Aptalis Pharma Ltd | Formula nutricional predigerida |
| KR101355018B1 (ko) * | 2010-12-13 | 2014-01-24 | 노부오 구보 | 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방용 동물사료 첨가제 및 이를 포함하는 동물사료용 조성물 |
| RU2494726C2 (ru) * | 2011-04-11 | 2013-10-10 | Общество с Ограниченной Ответственностью "Производственная Торговая Компания "Лактив" | Способ профилактики и лечения грибковой инфекции у больных с голосовыми протезами |
| EP3150257A1 (en) * | 2015-09-30 | 2017-04-05 | Buga, Doris | A method for producing a composition for strengthening the immune system |
| CA3026402A1 (en) | 2017-12-05 | 2019-06-05 | James F. Kane | Water-soluble cannabinoids and methods of making same |
| US11298379B2 (en) * | 2020-04-16 | 2022-04-12 | James F. Kane | Compositions comprising milk fat globules and methods of making same |
| CN113855787A (zh) * | 2020-06-30 | 2021-12-31 | 北京大学 | 乳清蛋白作为冠状病毒广谱抑制剂的用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2796378A (en) * | 1954-04-09 | 1957-06-18 | Jr Edgar A Ferguson | Methionine free reaction product of a water-soluble copper salt and lactalbumin hydrolysate as fungicide |
| GB1050756A (da) * | 1964-09-10 | 1900-01-01 | ||
| US4397927A (en) * | 1982-03-25 | 1983-08-09 | Brog Roy A | Imitation milk compositions and aqueous dispersions prepared therefrom |
| US4918008A (en) | 1985-01-18 | 1990-04-17 | Gauri Kailash Kumar | Process for the preparation of protein hydrolysate and medicaments containing these hydrolysates |
| JPS62249931A (ja) | 1986-04-21 | 1987-10-30 | Morinaga Milk Ind Co Ltd | 抗菌性組成物 |
| JPH085798B2 (ja) * | 1987-02-02 | 1996-01-24 | 紀夫 多田 | 抗菌剤 |
| ES2043279T3 (es) * | 1989-06-07 | 1993-12-16 | Kao Corp | Emulsion comestible de aceite en agua. |
| JP2673320B2 (ja) | 1990-01-25 | 1997-11-05 | 雪印乳業株式会社 | う蝕原菌付着阻止剤 |
| JPH04159232A (ja) * | 1990-08-21 | 1992-06-02 | Yakult Honsha Co Ltd | 日和見感染症予防・治療用経口組成物 |
| CA2094570A1 (en) * | 1992-05-27 | 1993-11-28 | Jerome F. Trumbetas | Enzymatic protein process and product |
| AU5896194A (en) | 1992-10-30 | 1994-05-24 | Cancer Research Fund Of Contra Costa | Anti-diarrheic product and method of treating rotavirus-associated infection |
| US5785984A (en) * | 1993-02-05 | 1998-07-28 | Kao Corporation | Taste-modifying method and bitterness-decreasing method |
| US6197356B1 (en) * | 1993-08-03 | 2001-03-06 | Immunopath Profile, Inc. | Process for preparing hypoallergenic foods |
| DK0776214T3 (da) * | 1994-08-16 | 1999-11-29 | Catharina Svanborg | Antibakterialt præparat indeholdende multimert alfa-lactalbumin |
| JP4233615B2 (ja) * | 1996-08-22 | 2009-03-04 | 森永乳業株式会社 | 経口抗ヒト爪白癬及び／又は爪白癬以外のヒト足部白癬用医薬品 |
| JP3819441B2 (ja) | 1997-01-09 | 2006-09-06 | 森永乳業株式会社 | ラクトフェリン錠剤 |
| IE970541A1 (en) | 1997-07-25 | 1999-01-27 | Michael Anthony Folan | Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity |
| JP4129566B2 (ja) * | 1997-09-05 | 2008-08-06 | 大塚製薬株式会社 | 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤 |
| US6287590B1 (en) | 1997-10-02 | 2001-09-11 | Esperion Therapeutics, Inc. | Peptide/lipid complex formation by co-lyophilization |
| AUPP051497A0 (en) | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
| US6126955A (en) * | 1998-04-16 | 2000-10-03 | University Of Utah Research Foundation | Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials |
| JP2002519332A (ja) * | 1998-06-26 | 2002-07-02 | エヌ・ヴェー・ニュートリシア | 微生物によって引き起こされる表面感染症の治療または予防に使用するための医薬調製物 |
| JP2000119257A (ja) * | 1998-08-14 | 2000-04-25 | Nippon Nohyaku Co Ltd | ピリダジノン誘導体 |
| GB9903584D0 (en) | 1999-02-18 | 1999-04-07 | Univ Leeds | Modified calycins |
| JP3662445B2 (ja) * | 1999-06-30 | 2005-06-22 | 花王株式会社 | 油中水型乳化油脂組成物 |
| US7169416B2 (en) * | 2001-05-23 | 2007-01-30 | Nutricopia, Inc. | Nutritional frozen dessert and methods of manufacture |
| US20030165606A1 (en) | 2001-07-18 | 2003-09-04 | Lasekan John B. | Anti-regurgitation formula and uses thereof |
| EP1319407A1 (en) * | 2001-12-14 | 2003-06-18 | Montoie Import-Export S.A. | Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
-
2002
- 2002-08-20 DK DK02796345T patent/DK1427436T3/da active
- 2002-08-20 PT PT02796345T patent/PT1427436E/pt unknown
- 2002-08-20 CA CA2458146A patent/CA2458146C/en not_active Expired - Fee Related
- 2002-08-20 NZ NZ531639A patent/NZ531639A/en not_active IP Right Cessation
- 2002-08-20 CN CN028210786A patent/CN1578670B/zh not_active Expired - Fee Related
- 2002-08-20 JP JP2003522566A patent/JP4532900B2/ja not_active Expired - Fee Related
- 2002-08-20 DE DE60227389T patent/DE60227389D1/de not_active Expired - Lifetime
- 2002-08-20 ES ES02796345T patent/ES2309228T3/es not_active Expired - Lifetime
- 2002-08-20 EP EP02796345A patent/EP1427436B1/en not_active Expired - Lifetime
- 2002-08-20 AU AU2002356112A patent/AU2002356112B2/en not_active Ceased
- 2002-08-20 RU RU2004108040/13A patent/RU2305547C2/ru not_active IP Right Cessation
- 2002-08-20 US US10/487,616 patent/US7687074B2/en not_active Expired - Lifetime
- 2002-08-20 KR KR1020047002518A patent/KR100907959B1/ko not_active Expired - Fee Related
- 2002-08-20 AT AT02796345T patent/ATE399562T1/de active
- 2002-08-20 WO PCT/IE2002/000121 patent/WO2003018049A2/en not_active Ceased
-
2010
- 2010-01-30 US US12/657,884 patent/US7972629B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1427436B1 (en) | 2008-07-02 |
| WO2003018049A2 (en) | 2003-03-06 |
| US7972629B2 (en) | 2011-07-05 |
| US7687074B2 (en) | 2010-03-30 |
| PT1427436E (pt) | 2008-09-08 |
| JP2005501863A (ja) | 2005-01-20 |
| JP4532900B2 (ja) | 2010-08-25 |
| CN1578670A (zh) | 2005-02-09 |
| US20050042299A1 (en) | 2005-02-24 |
| KR100907959B1 (ko) | 2009-07-16 |
| DE60227389D1 (de) | 2008-08-14 |
| NZ531639A (en) | 2006-02-24 |
| AU2002356112B2 (en) | 2007-11-08 |
| CN1578670B (zh) | 2013-09-04 |
| EP1427436A2 (en) | 2004-06-16 |
| US20100209526A1 (en) | 2010-08-19 |
| CA2458146A1 (en) | 2003-03-06 |
| WO2003018049A3 (en) | 2003-11-06 |
| ATE399562T1 (de) | 2008-07-15 |
| CA2458146C (en) | 2012-07-24 |
| KR20040041579A (ko) | 2004-05-17 |
| RU2004108040A (ru) | 2005-09-27 |
| RU2305547C2 (ru) | 2007-09-10 |
| ES2309228T3 (es) | 2008-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1427436T3 (da) | Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion | |
| WO2003082188A3 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
| IL139230A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear | |
| ATE301654T1 (de) | Naphthyridinderivate | |
| PT914110E (pt) | Metodo de modulacao da micro-circulacao | |
| WO2001047913A3 (de) | Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
| CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
| ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
| SE9903611D0 (sv) | Novel compounds III | |
| WO2004033479A3 (en) | Retroyclins: antiviral and antimicrobial peptides | |
| MXPA03006266A (es) | Uso de l-carnitina como agente estabilizador de proteinas. | |
| CN114712355A (zh) | Rhps4在制备抑制人类病原菌药物中的应用及其药物 | |
| RU2188665C1 (ru) | Противовирусное и антибактериальное средство "интерлизин" | |
| NZ587372A (en) | Treatment of bacterial, protozoan infections and cancer with a mixture of at least three different human interferon alpha proteins | |
| US20140329780A1 (en) | Inhibitor of colonisation of mucosa | |
| AU2003294834A1 (en) | Anthranilic acid amide derivatives and their pharmaceutical use | |
| RU2180532C2 (ru) | Способ лечения папилломатоза | |
| AP1629A (en) | Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes. | |
| Waghchaure et al. | A REVIEW ON: COVID-19, THE STEP TOWARDS PREVENTION, TREATMENT | |
| EA200501765A3 (ru) | Средство для лечения болезней суставов | |
| SE9903609D0 (sv) | Novel compounds I | |
| SE9903610D0 (sv) | Novel compounds II |